Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic fibrinogen before radical cystectomy
IRCT20191013045091N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-blind trial of Fibrinogen human in bladder cancer (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Amount of bleeding during surgery. Started Dec 2019; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
bladder cancer
Beyond the preview
Go deeper on IRCT20191013045091N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191013045091N1.